Innoviva's subsidiary is recognized for its products ZEVTERA and XACDURO, which treat serious infections.
1 report, 1 independent
Updated Aug 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Innoviva's subsidiary is recognized for its products ZEVTERA and XACDURO, which treat serious infections.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Innoviva (United States)
company in Burlingame, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- Business WireInnoviva Specialty Therapeutics’ Antimicrobial Therapies ZEVTERA® and XACDURO® Nominated for the 2025 Prix Galien USA Best Pharmaceutical Product Award WALTHAM, Mass., August 13, 2025--(BUSINESS WIRE